BioHaven’s Troriluzole Fails Co-Primary Endpoints in Phase 2 Trial for Mild-to-Moderate Alzheimer’s Disease
BioHaven Pharmaceuticals announced the outcome from a focused analysis of the topline co-primary and key secondary data from its Phase […]
Fake Investigator Going to Prison for 28 Years: Two Washington State Trial Site Operations Duped Sponsors & CRO
Just over a year ago, TrialSite introduced the exploits of the fake principal investigator named Sani Anwar, owner of Zain […]
Nation’s Largest Chain of Hospitals Under Fire by Nurses Union
A large health care workers union has recently made very serious allegations against a major U.S. health care company. Specifically, […]
Levo Therapeutics Announces Mixed Results from Phase 3 CARE-PWS Study of LV-101 (Intranasal Carbetocin) for the Treatment of Prader-Willi Syndrome
Levo Therapeutics announced top-line results from the Phase 3 CARE-PWS clinical study evaluating LV-101 (intranasal carbetocin) for the treatment of Prader-Willi Syndrome (PWS). […]
Lundbeck Discontinues Phase 2 Study of Lu AF11167 in Patients with Schizophrenia
Lundbeck announced a decision to discontinue a phase II proof of concept clinical study of Lu AF11167 in patients with schizophrenia who are […]
Genentech Reports Mixed Results from Phase 3 Program of Etrolizumab for Moderate to Severe Active Ulcerative Colitis
Genentech announced topline results from its Phase III study program evaluating the etrolizumab in patients with moderate to severely active ulcerative […]
India’s Authorities Approve Start of WHO Solidarity Trial in Gujarat India & Challenges at GMERs
The World Health Organization’s Solidarity Trial covering COVID-19 launches in Gujarat India at sites including SVP College in Ahmedabad, GMERs, […]
Lawsuit Claim: Iowa State-Owned I/DD Provider Transformed by Rogue ‘Investigators’ into Research ‘Den of Iniquity’
A federal civil lawsuit has been filed against a state agency and several officials alleging a conspiracy to silence complaints about […]
University of Iowa Audit Reveals Shortcomings in its Human Subjects Research Program
The University of Iowa (UI) generates $467 million in external research funding for research—reaching an all-time high for the academic […]
China’s ‘Thousand Talents Program’ Pierces Moffitt Cancer Center & Director Must Pay with Job
Moffit Cancer Center CEO Dr. Alan List is purportedly leaving the institution due a violation of the cancer center’s rules […]
